Skip to main content
. 2017 Jan 12;7:40374. doi: 10.1038/srep40374

Figure 2.

Figure 2

Kaplan-Meier survival curve for patients with activating EGFR mutations stratified by (a) histological type, (b) disease type, (c) EGFR TKI therapy. P-value indicates significance levels from the comparison of survival curves using the Log-rank test.